In laryngeal and prostate cancer models, expression of hg19_circ_0005033 in CD133+/CD44+ CSCs has been allied with EMT promotion and the subsequent increase in CSC migratory and invasive capabilities, via Jak2/STAT5A signaling upregulation [170,171]. The gene discussed is CD44; the disease is prostate cancer.